Andractim for HAART-associated breast enlargement.
D023241:Antiretroviral Therapy, Highly Active / Q000009:adverse effects*; D013196:Dihydrotestosterone / Q000627:therapeutic use*; D005260:Female; D006177:Gynecomastia / Q000139:chemically induced / Q000188:drug therapy*; D006801:Humans; D008297:Male; D014481:United States
D013196:Dihydrotestosterone